Christopher Yea Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Christopher Yea.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Christopher Yea. Christopher Yea is Chief Development Officer in KalVista Pharmaceuticals, Inc. ($CBYL).
Latest Insider Trading Transactions of Christopher Yea
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 06 2021 | KALV | KalVista Pharmaceu ... | Yea Christopher | Chief Development O ... | Sell | S | 24.84 | 5,000 | 124,197 | 42,969 | 48 K to 43 K (-10.42 %) |
| Feb 25 2021 | KALV | KalVista Pharmaceu ... | Yea Christopher | Chief Development O ... | Sell | S | 31.87 | 500 | 15,933 | 47,969 | 48.5 K to 48 K (-1.03 %) |
| Feb 25 2021 | KALV | KalVista Pharmaceu ... | Yea Christopher | Chief Development O ... | Sell | S | 32.94 | 3,311 | 109,059 | 48,469 | 51.8 K to 48.5 K (-6.39 %) |
| Feb 25 2021 | KALV | KalVista Pharmaceu ... | Yea Christopher | Chief Development O ... | Sell | S | 33.74 | 10,389 | 350,572 | 51,780 | 62.2 K to 51.8 K (-16.71 %) |
| Feb 25 2021 | KALV | KalVista Pharmaceu ... | Yea Christopher | Chief Development O ... | Sell | S | 35.39 | 800 | 28,314 | 62,169 | 63 K to 62.2 K (-1.27 %) |
| Feb 08 2021 | KALV | KalVista Pharmaceu ... | Yea Christopher | Chief Development O ... | Option Exercise | A | 10.20 | 20,000 | 204,000 | 20,000 | |
| Feb 08 2021 | KALV | KalVista Pharmaceu ... | Yea Christopher | Chief Development O ... | Option Exercise | A | 24.23 | 31,000 | 751,130 | 31,000 | |
| Dec 18 2020 | KALV | KalVista Pharmaceu ... | Yea Christopher | Chief Development O ... | Option Exercise | A | 10.20 | 80,000 | 816,000 | 80,000 | |
| Oct 22 2020 | KALV | KalVista Pharmaceu ... | Yea Christopher | Chief Development O ... | Sell | S | 19.02 | 2,544 | 48,389 | 67,969 | 70.5 K to 68 K (-3.61 %) |
| Oct 22 2020 | KALV | KalVista Pharmaceu ... | Yea Christopher | Chief Development O ... | Sell | S | 17.68 | 3,500 | 61,893 | 70,513 | 74 K to 70.5 K (-4.73 %) |
| Oct 22 2020 | KALV | KalVista Pharmaceu ... | Yea Christopher | Chief Development O ... | Sell | S | 18.01 | 2,302 | 41,467 | 74,013 | 76.3 K to 74 K (-3.02 %) |
| Oct 22 2020 | KALV | KalVista Pharmaceu ... | Yea Christopher | Chief Development O ... | Sell | S | 17.27 | 5,640 | 97,419 | 76,315 | 82 K to 76.3 K (-6.88 %) |
| Oct 20 2020 | KALV | KalVista Pharmaceu ... | Yea Christopher | Chief Development O ... | Sell | S | 17.00 | 914 | 15,539 | 81,955 | 82.9 K to 82 K (-1.10 %) |
| Feb 07 2020 | KALV | KalVista Pharmaceu ... | Yea Christopher | Chief Development O ... | Sell | S | 17.10 | 100 | 1,710 | 82,869 | 83 K to 82.9 K (-0.12 %) |
| Dec 26 2019 | KALV | KalVista Pharmaceu ... | Yea Christopher | Chief Development O ... | Option Exercise | M | 0.00 | 2,646 | 11 | 87,390 | |
| Dec 26 2019 | KALV | KalVista Pharmaceu ... | Yea Christopher | Chief Development O ... | Sell | S | 17.02 | 2,646 | 45,025 | 82,969 | 85.6 K to 83 K (-3.09 %) |
| Dec 26 2019 | KALV | KalVista Pharmaceu ... | Yea Christopher | Chief Development O ... | Buy | M | 0.00 | 2,646 | 11 | 85,615 | 83 K to 85.6 K (+3.19 %) |
| Dec 16 2019 | KALV | KalVista Pharmaceu ... | Yea Christopher | Chief Development O ... | Option Exercise | M | 0.00 | 3,010 | 13 | 90,036 | |
| Dec 16 2019 | KALV | KalVista Pharmaceu ... | Yea Christopher | Chief Development O ... | Option Exercise | M | 0.00 | 1,500 | 6 | 93,046 | |
| Dec 16 2019 | KALV | KalVista Pharmaceu ... | Yea Christopher | Chief Development O ... | Option Exercise | M | 0.00 | 199 | 1 | 94,546 | |
| Dec 16 2019 | KALV | KalVista Pharmaceu ... | Yea Christopher | Chief Development O ... | Sell | S | 17.05 | 3,010 | 51,318 | 82,969 | 86 K to 83 K (-3.50 %) |
| Dec 16 2019 | KALV | KalVista Pharmaceu ... | Yea Christopher | Chief Development O ... | Buy | M | 0.00 | 3,010 | 13 | 85,979 | 83 K to 86 K (+3.63 %) |
| Dec 16 2019 | KALV | KalVista Pharmaceu ... | Yea Christopher | Chief Development O ... | Sell | S | 17.05 | 1,500 | 25,568 | 82,969 | 84.5 K to 83 K (-1.78 %) |
| Dec 16 2019 | KALV | KalVista Pharmaceu ... | Yea Christopher | Chief Development O ... | Buy | M | 0.00 | 1,500 | 6 | 84,469 | 83 K to 84.5 K (+1.81 %) |
| Dec 16 2019 | KALV | KalVista Pharmaceu ... | Yea Christopher | Chief Development O ... | Sell | S | 17.00 | 199 | 3,383 | 82,969 | 83.2 K to 83 K (-0.24 %) |
| Dec 16 2019 | KALV | KalVista Pharmaceu ... | Yea Christopher | Chief Development O ... | Buy | M | 0.00 | 199 | 1 | 83,168 | 83 K to 83.2 K (+0.24 %) |
| Jul 24 2019 | KALV | KalVista Pharmaceu ... | Yea Christopher | Chief Development O ... | Option Exercise | M | 0.00 | 7,355 | 32 | 94,745 | |
| Jul 24 2019 | KALV | KalVista Pharmaceu ... | Yea Christopher | Chief Development O ... | Sell | S | 18.35 | 7,355 | 134,930 | 82,969 | 90.3 K to 83 K (-8.14 %) |
| Jul 24 2019 | KALV | KalVista Pharmaceu ... | Yea Christopher | Chief Development O ... | Buy | M | 0.00 | 7,355 | 32 | 90,324 | 83 K to 90.3 K (+8.86 %) |
| May 17 2019 | KALV | KalVista Pharmaceu ... | Yea Christopher | Chief Development O ... | Option Exercise | A | 24.23 | 27,900 | 676,017 | 27,900 | |
| Apr 23 2019 | KALV | KalVista Pharmaceu ... | Yea Christopher | Chief Development O ... | Option Exercise | M | 0.00 | 7,355 | 32 | 102,100 | |
| Apr 23 2019 | KALV | KalVista Pharmaceu ... | Yea Christopher | Chief Development O ... | Sell | S | 26.79 | 1,000 | 26,786 | 82,969 | 84 K to 83 K (-1.19 %) |
| Apr 23 2019 | KALV | KalVista Pharmaceu ... | Yea Christopher | Chief Development O ... | Sell | S | 25.92 | 6,355 | 164,744 | 83,969 | 90.3 K to 84 K (-7.04 %) |
| Apr 23 2019 | KALV | KalVista Pharmaceu ... | Yea Christopher | Chief Development O ... | Buy | M | 0.00 | 7,355 | 32 | 90,324 | 83 K to 90.3 K (+8.86 %) |
| Jan 29 2019 | KALV | KalVista Pharmaceu ... | Yea Christopher | Chief Development O ... | Option Exercise | M | 0.00 | 5,453 | 23 | 109,455 | |
| Jan 29 2019 | KALV | KalVista Pharmaceu ... | Yea Christopher | Chief Development O ... | Sell | S | 17.06 | 5,453 | 93,015 | 82,969 | 88.4 K to 83 K (-6.17 %) |
| Jan 29 2019 | KALV | KalVista Pharmaceu ... | Yea Christopher | Chief Development O ... | Buy | M | 0.00 | 5,453 | 23 | 88,422 | 83 K to 88.4 K (+6.57 %) |
| Jan 24 2019 | KALV | KalVista Pharmaceu ... | Yea Christopher | Chief Development O ... | Option Exercise | M | 0.00 | 600 | 3 | 114,908 | |
| Jan 24 2019 | KALV | KalVista Pharmaceu ... | Yea Christopher | Chief Development O ... | Option Exercise | M | 0.00 | 1,302 | 6 | 115,508 | |
| Jan 24 2019 | KALV | KalVista Pharmaceu ... | Yea Christopher | Chief Development O ... | Sell | S | 17.01 | 600 | 10,205 | 82,969 | 83.6 K to 83 K (-0.72 %) |
| Jan 24 2019 | KALV | KalVista Pharmaceu ... | Yea Christopher | Chief Development O ... | Buy | M | 0.00 | 600 | 3 | 83,569 | 83 K to 83.6 K (+0.72 %) |
| Jan 24 2019 | KALV | KalVista Pharmaceu ... | Yea Christopher | Chief Development O ... | Sell | S | 17.00 | 1,302 | 22,139 | 82,969 | 84.3 K to 83 K (-1.55 %) |
| Jan 24 2019 | KALV | KalVista Pharmaceu ... | Yea Christopher | Chief Development O ... | Buy | M | 0.00 | 1,302 | 6 | 84,271 | 83 K to 84.3 K (+1.57 %) |
| Sep 20 2018 | KALV | KalVista Pharmaceu ... | Yea Christopher | Chief Development O ... | Option Exercise | A | 16.08 | 52,600 | 845,808 | 52,600 | |
| Sep 20 2018 | KALV | KalVista Pharmaceu ... | Yea Christopher | Chief Development O ... | Option Exercise | A | 16.08 | 52,600 | 845,808 | 52,600 | |
| Jun 06 2018 | KALV | KalVista Pharmaceu ... | Yea Christopher | Chief Development O ... | Option Exercise | A | 8.21 | 53,500 | 439,235 | 53,500 | |
| May 26 2017 | CBYL | KalVista Pharmaceu ... | Yea Christopher | Chief Development O ... | Option Exercise | A | 7.07 | 33,800 | 238,966 | 33,800 | |
| Nov 29 2016 | CBYL | KalVista Pharmaceu ... | Yea Christopher | Chief Development O ... | Option Exercise | A | 0.01 | 116,810 | 1,635 | 116,810 | |
| Nov 29 2016 | CBYL | KalVista Pharmaceu ... | Yea Christopher | Chief Development O ... | Grant | A | 0.00 | 82,969 | 0 | 82,969 | 0 to 83 K |
Page: 1